Literature DB >> 25677717

Rare disease registries classification and characterization: a data mining approach.

Michele Santoro1, Alessio Coi, Michele Lipucci Di Paola, Anna Maria Bianucci, Sabina Gainotti, Emanuela Mollo, Domenica Taruscio, Luciano Vittozzi, Fabrizio Bianchi.   

Abstract

BACKGROUND: The European Commission and Patients Organizations identify rare disease registries (RDRs) as strategic instruments to develop research and improve knowledge in the field of rare diseases. Interoperability between RDRs is needed for research activities, validation of therapeutic treatments, and public health actions. Sharing and comparing information requires a uniform and standardized way of data collection, so levels of interconnection between RDRs with similar aims and/or nature of data should be identified. The objective of this study is to define a classification and characterization of RDRs in order to identify different profiles and informative needs.
METHODS: Exploratory statistical analyses (cluster analysis and random forest) were applied to data derived from the EPIRARE project ('Building Consensus and Synergies for the EU Rare Disease Patient Registration') survey on the activities and needs of RDRs.
RESULTS: The cluster analysis identified 3 main typologies of RDRs: public health, clinical and genetic research, and treatment registries. The analysis of the most informative variables, identified by the random forest method, led to the characterization of 3 types of RDRs and the definition of different profiles and informative needs.
CONCLUSIONS: These results represent a useful source of information to facilitate the harmonization and interconnection of RDRs in accordance with the different profiles identified. It could help sharing the information between RDRs with similar profiles and, whenever possible, interconnections between registries with different profiles.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 25677717     DOI: 10.1159/000369993

Source DB:  PubMed          Journal:  Public Health Genomics        ISSN: 1662-4246            Impact factor:   2.000


  8 in total

1.  The RUDY study platform - a novel approach to patient driven research in rare musculoskeletal diseases.

Authors:  M K Javaid; L Forestier-Zhang; L Watts; A Turner; C Ponte; H Teare; D Gray; N Gray; R Popert; J Hogg; J Barrett; R Pinedo-Villanueva; C Cooper; R Eastell; N Bishop; R Luqmani; P Wordsworth; J Kaye
Journal:  Orphanet J Rare Dis       Date:  2016-11-08       Impact factor: 4.123

2.  The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care.

Authors:  Marie De Antonio; Céline Dogan; Ferroudja Daidj; Bruno Eymard; Jack Puymirat; Jean Mathieu; Cynthia Gagnon; Sandrine Katsahian; Dalil Hamroun; Guillaume Bassez
Journal:  Orphanet J Rare Dis       Date:  2019-06-03       Impact factor: 4.123

3.  Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy).

Authors:  Alessio Coi; Simone Barsotti; Michele Santoro; Fabio Almerigogna; Elena Bargagli; Marzia Caproni; Giacomo Emmi; Bruno Frediani; Serena Guiducci; Marco Matucci Cerinic; Marta Mosca; Paola Parronchi; Renato Prediletto; Enrico Selvi; Gabriele Simonini; Antonio Gaetano Tavoni; Fabrizio Bianchi; Anna Pierini
Journal:  Orphanet J Rare Dis       Date:  2021-02-17       Impact factor: 4.123

4.  Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi).

Authors:  Daphne H Schoenmakers; Shanice Beerepoot; Sibren van den Berg; Laura Adang; Annette Bley; Jaap-Jan Boelens; Francesca Fumagalli; Wim G Goettsch; Sabine Grønborg; Samuel Groeschel; Peter M van Hasselt; Carla E M Hollak; Caroline Lindemans; Fanny Mochel; Peter G M Mol; Caroline Sevin; Ayelet Zerem; Ludger Schöls; Nicole I Wolf
Journal:  Orphanet J Rare Dis       Date:  2022-02-14       Impact factor: 4.123

5.  Recommendations for Improving the Quality of Rare Disease Registries.

Authors:  Yllka Kodra; Jérôme Weinbach; Manuel Posada-de-la-Paz; Alessio Coi; S Lydie Lemonnier; David van Enckevort; Marco Roos; Annika Jacobsen; Ronald Cornet; S Faisal Ahmed; Virginie Bros-Facer; Veronica Popa; Marieke Van Meel; Daniel Renault; Rainald von Gizycki; Michele Santoro; Paul Landais; Paola Torreri; Claudio Carta; Deborah Mascalzoni; Sabina Gainotti; Estrella Lopez; Anna Ambrosini; Heimo Müller; Robert Reis; Fabrizio Bianchi; Yaffa R Rubinstein; Hanns Lochmüller; Domenica Taruscio
Journal:  Int J Environ Res Public Health       Date:  2018-08-03       Impact factor: 3.390

6.  Rare disease registries: potential applications towards impact on development of new drug treatments.

Authors:  Marijke C Jansen-van der Weide; Charlotte M W Gaasterland; Kit C B Roes; Caridad Pontes; Roser Vives; Arantxa Sancho; Stavros Nikolakopoulos; Eric Vermeulen; Johanna H van der Lee
Journal:  Orphanet J Rare Dis       Date:  2018-09-05       Impact factor: 4.123

7.  Communication Needs for Individuals With Rare Diseases Within and Around the Healthcare System of Northern Ireland.

Authors:  Ashleen L Crowe; Amy Jayne McKnight; Helen McAneney
Journal:  Front Public Health       Date:  2019-08-21

Review 8.  Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter?

Authors:  Sandra Brasil; Carlota Pascoal; Rita Francisco; Vanessa Dos Reis Ferreira; Paula A Videira; And Gonçalo Valadão
Journal:  Genes (Basel)       Date:  2019-11-27       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.